IIL introduces paediatric dose of indigenous Hepatitis A Vaccine

According to Dr K Anand Kumar, MD, Indian Immunologicals, Havisure (0.5 ml) will contribute to a brighter and healthier future for our younger generation

Hyderabad-based Indian Immunologicals Limited (IIL) announced the launch of its latest breakthrough: the pediatric dose of India's first indigenous Hepatitis A vaccine, Havisure (0.5 ml).

This launch marks a significant milestone in IIL's ongoing commitment to providing affordable and effective vaccines for all, especially for the most vulnerable sections of society, particularly children.

Dr K Anand Kumar, MD, Indian Immunologicals, said, "We are delighted to introduce the paediatric dose of Havisure, the first indigenously developed Hepatitis A vaccine in India. IIL is the single largest contributor to the self-sufficiency of vaccines in the country, this launch is a testament to IIL's unwavering dedication to innovation and public health. As we celebrate Teachers' Day, we are reminded of shaping a brighter future for children. We are confident that this vaccine will contribute to a brighter and healthier future for our younger generation. IIL’s endeavour to make indigenous vaccines will give necessary impetus to Make in India efforts.”